613P Effect of prior use of anti-VEGF agents on overall survival in patients with refractory metastatic colorectal cancer: A post-hoc analysis of the phase III SUNLIGHT trial
Gerald W. Prager, Julien Taı̈eb, Marwan Fakih, Fortunato Ciardiello, Eric Van Cutsem, M.E. Elez Fernandez, F.J.S.M. Cruz, Lucjan Wyrwicz, Zsuzsanna Pápai, Pierre-Guillaume Poureau, Gábor Liposits, Chiara Cremolini, Igor Bondarenko, Dominik Paul Modest, Elizabeth Calleja, L. Roby, Valentine Barboux, N. Caussé-Amellal, Josep Tabernero
Topics & Concepts
MedicineBevacizumabInternal medicineRegimenPost-hoc analysisColorectal cancerSubgroup analysisOncologyRefractory (planetary science)GastroenterologyChemotherapyCancerConfidence intervalAstrobiologyPhysicsColorectal Cancer Treatments and StudiesCancer Treatment and PharmacologyGastric Cancer Management and Outcomes